Your browser doesn't support javascript.
loading
Remdesivir as a broad-spectrum antiviral drug against COVID-19.
Hong, Y-N; Xu, J; Sasa, G B K; Zhou, K-X; Ding, X-F.
Affiliation
  • Hong YN; Zhejiang Sci-Tech University, Zhejiang, HangZhou, China. bdd114@163.com.
Eur Rev Med Pharmacol Sci ; 25(1): 541-548, 2021 Jan.
Article in En | MEDLINE | ID: mdl-33506946
ABSTRACT

OBJECTIVE:

List the clinical data of the role of remdesivir in COVID-19, and try to make an objective evaluation and analyze its feasibility. MATERIALS AND

METHODS:

The keywords of "remdesivir", "COVID-19" and "SARS-CoV-2" were systematically searched in PubMed and Web of Science. After removing the repetitions, we summarize articles, letters, and comments on remdesivir in the treatment of COVID-19.

RESULTS:

In this review, we summarize clinical case of using remdesivir in the treatment of COVID-19, analyzed the final treatment results, and judged whether the drug was effective for the treatment of COVID-19. Also, attention was paid to the side effects of the drug.

CONCLUSIONS:

According to the clinical results, it was found that remdesivir was effective in the treatment of COVID-19. The drug has side effects, but the symptoms were mild and disappeared immediately after discontinuation of medication.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Affiliation country: China